Delivery Order SPE2DB20D3103-SPE2DB24FP1F4

Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 100 capsules of the medication Tacrolimus 0.5 mg (immediate release) to the Defense Logistics Agency (DLA). The contract, a firm fixed-price delivery order valued at $1,856.62, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of October 21,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.57 firm fixed-price delivery order contract covers the supply of Tacrolimus 1 mg capsules (immediate release) to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $7,696.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used in various medical treatments. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,474.11 firm fixed-price delivery order is for the supply of 100 capsules of 5 mg Tacrolimus (an immunosuppressant medication). The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2022. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB22FQ15H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, a medication used to prevent organ rejection in transplant patients. The contract has a ceiling value of $2,408.32 and was awarded on September 21, 2022, with a completion date of September 22, 2022. It is a...
This federal contract award, valued at $1,221.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a prescription medication. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,462.10 firm-fixed-price delivery order is for the supply of 100 units of the medication Tacrolimus 1 mg capsules. This contract does not have a set-aside designation, indicating open competition. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,622.72, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used in transplant patients. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,551.67 firm fixed-price delivery order is for the supply of 100 units of the medication Tacrolimus 1 mg capsule (immediate release). The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,514.24 firm fixed-price delivery order is for the supply of 100 units of the drug Tacrolimus 5 mg capsules, an immunosuppressant medication. The contract has an ultimate completion date of July 25, 2024 and is not designated as a set-aside. This award is associated with a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP1F4
    Delivery Order

This federal contract award, valued at $22,833.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, a medication used to prevent organ rejection in transplant patients.

The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/16/25, 11:44 AM